Brookstone Capital Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-12,560
| Closed | -$27K | – | 722 |
|
|
2021
Q1 | $27K | Sell |
12,560
-150
| -1% | -$322 | ﹤0.01% | 500 |
|
|
2020
Q4 | $28K | Hold |
12,710
| – | – | ﹤0.01% | 465 |
|
|
2020
Q3 | $34K | Buy |
+12,710
| New | +$34K | ﹤0.01% | 437 |
|
|
2020
Q2 | – | Sell |
-10,150
| Closed | -$20K | – | 374 |
|
|
2020
Q1 | $20K | Buy |
+10,150
| New | +$20K | ﹤0.01% | 328 |
|